Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × aldesleukin × Clear all

Sponsor

Conditions

Melanoma 46 Neoplasm Metastasis 19 Skin Neoplasms 14 Carcinoma, Renal Cell 13 Leukemia, Myeloid, Acute 11 Kidney Neoplasms 10 Leukemia 9 Neoplasms 7 Uterine Cervical Neoplasms 5 Lymphoma 5 Congenital Abnormalities 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Neuroblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Vaginal Neoplasms 2 Penile Neoplasms 2 Papillomavirus Infections 2 Oropharyngeal Neoplasms 2 Melanoma, Experimental 2 Lymphoma, Mantle-Cell 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Brain Neoplasms 2

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡